Understanding and targeting anoikis in metastasis for cancer therapies. (1st December 2022)

• Record Type: Journal Article
• Authors: Sattari Fard, Farzad ; Jalilzadeh, Nazila; Mehdizadeh, Amir; Sajjadian, Fakhrosadat; Velaei, Kobra
• Is Part Of: Cell biology international. Volume 47:Number 4(2023)
• Page Start: 683
• Page End: 698
• Publication Date: 2022-12-01
• Subjects: anoikis -- anoikis resistance -- cancer -- metastasis; Cytology -- Periodicals; Cells -- Periodicals; 571.605
• DOI: 10.1002/cbin.11970
• Languages: English
• ISSNs: 1065-6995

Abstract

Abstract: The development of effective treatments for cancers requires investigations for a more detailed and comprehensive understanding of the basic cellular mechanisms involved in carcinogenesis, cancer progression, and metastasis. One of those driving mechanisms is anoikis, a special type of apoptosis, which is induced by losing anchorage from the extracellular matrix (ECM). In other words, resisting death in detached cells (cells without ECM) forms an anoikis‐resistant phenotype. Since the anoikis‐resistance state compensates for the initial steps of cancer metastasis, this review aimed to discuss mechanisms of gaining anoikis/anoikis resistance phenotype in tumor cells. Finally, we highlighted the significance of anoikis in malignancies so as to provide clear insight into cancer diagnosis and therapy development.